Filed: 5/15/2026ACC: 0001420506-26-001036
📋 What this filing means
PROSIGHT MANAGEMENT, LP filed this quarterly 13F‑HR report disclosing 46 equity positions with a total reported market value of $609.82M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
46
Positions
$609.82M
Total AUM (reported)
42.46M
Total Shares
Allocation by class
COM$362.41M59.4%
COM NEW$63.51M10.4%
SHS$54.27M8.9%
SPON ADR$46.50M7.6%
COM CL A$42.54M7.0%
CL A COM$15.19M2.5%
COMMON STOCK$12.51M2.1%
Portfolio Concentration
Top 3$152.15M24.9%
4–10$244.50M40.1%
11–25$174.31M28.6%
Rest$38.86M6.4%
Top 3 weight
24.9%
Top 10 weight
65.0%
Voting Authority Distribution
Total shares with voting rights: 42.46M
Sole
Full voting authority
42.46M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole46
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings46
Rows:
NEKTAR THERAPEUTICS
SOLEShares735K
TypeSH
Market value$52.88M
8.67%
Sole
735K
Shared
0.00
None
0.00
BOSTON SCIENTIFIC CORP
SOLEShares795.55K
TypeSH
Market value$49.92M
8.19%
Sole
795.55K
Shared
0.00
None
0.00
JANUX THERAPEUTICS INC
SOLEShares3.55M
TypeSH
Market value$49.34M
8.09%
Sole
3.55M
Shared
0.00
None
0.00
PROCEPT BIOROBOTICS CORP
SOLEShares1.95M
TypeSH
Market value$48.64M
7.98%
Sole
1.95M
Shared
0.00
None
0.00
GALAPAGOS NV
SOLEShares1.55M
TypeSH
Market value$46.50M
7.63%
Sole
1.55M
Shared
0.00
None
0.00
GENEDX HOLDINGS CORP
SOLEShares523.46K
TypeSH
Market value$33.62M
5.51%
Sole
523.46K
Shared
0.00
None
0.00
SHATTUCK LABS INC
SOLEShares5M
TypeSH
Market value$32.18M
5.28%
Sole
5M
Shared
0.00
None
0.00
ADC THERAPEUTICS SA
SOLEShares8.30M
TypeSH
Market value$31.13M
5.10%
Sole
8.30M
Shared
0.00
None
0.00
KURA ONCOLOGY INC
SOLEShares3.36M
TypeSH
Market value$27.29M
4.48%
Sole
3.36M
Shared
0.00
None
0.00
ALNYLAM PHARMACEUTICALS INC
SOLEShares76K
TypeSH
Market value$25.15M
4.12%
Sole
76K
Shared
0.00
None
0.00
MEIRAGTX HLDGS PLC
SOLEShares2.63M
TypeSH
Market value$22.78M
3.73%
Sole
2.63M
Shared
0.00
None
0.00
ALKERMES PLC
SOLEShares513.63K
TypeSH
Market value$18.16M
2.98%
Sole
513.63K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares770K
TypeSH
Market value$17.99M
2.95%
Sole
770K
Shared
0.00
None
0.00
VEEVA SYS INC
SOLEShares86.48K
TypeSH
Market value$15.19M
2.49%
Sole
86.48K
Shared
0.00
None
0.00
ZYMEWORKS INC
SOLEShares539.05K
TypeSH
Market value$13.50M
2.21%
Sole
539.05K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares350K
TypeSH
Market value$12.71M
2.08%
Sole
350K
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares105K
TypeSH
Market value$11.69M
1.92%
Sole
105K
Shared
0.00
None
0.00
CONCENTRA GROUP HOLDINGS PAR
SOLEShares505.82K
TypeSH
Market value$10.85M
1.78%
Sole
505.82K
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares202.30K
TypeSH
Market value$10.67M
1.75%
Sole
202.30K
Shared
0.00
None
0.00
PHREESIA INC
SOLEShares1.10M
TypeSH
Market value$9.22M
1.51%
Sole
1.10M
Shared
0.00
None
0.00
ONKURE THERAPEUTICS INC
SOLEShares2.15M
TypeSH
Market value$8.92M
1.46%
Sole
2.15M
Shared
0.00
None
0.00
CORBUS PHARMACEUTICALS HLDGS
SOLEShares697.11K
TypeSH
Market value$6.55M
1.07%
Sole
697.11K
Shared
0.00
None
0.00
SCHRODINGER INC
SOLEShares510.58K
TypeSH
Market value$5.80M
0.95%
Sole
510.58K
Shared
0.00
None
0.00
EMERGENT BIOSOLUTIONS INC
SOLEShares639.12K
TypeSH
Market value$5.30M
0.87%
Sole
639.12K
Shared
0.00
None
0.00
ROIVANT SCIENCES LTD
SOLEShares180K
TypeSH
Market value$4.99M
0.82%
Sole
180K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
NEKTAR THERAPEUTICSSOLE | COM NEW | 735K | SH | $52.88M 8.67% | 735K | 0.00 | 0.00 |
BOSTON SCIENTIFIC CORPSOLE | COM | 795.55K | SH | $49.92M 8.19% | 795.55K | 0.00 | 0.00 |
JANUX THERAPEUTICS INCSOLE | COM | 3.55M | SH | $49.34M 8.09% | 3.55M | 0.00 | 0.00 |
PROCEPT BIOROBOTICS CORPSOLE | COM | 1.95M | SH | $48.64M 7.98% | 1.95M | 0.00 | 0.00 |
GALAPAGOS NVSOLE | SPON ADR | 1.55M | SH | $46.50M 7.63% | 1.55M | 0.00 | 0.00 |
GENEDX HOLDINGS CORPSOLE | COM CL A | 523.46K | SH | $33.62M 5.51% | 523.46K | 0.00 | 0.00 |
SHATTUCK LABS INCSOLE | COM | 5M | SH | $32.18M 5.28% | 5M | 0.00 | 0.00 |
ADC THERAPEUTICS SASOLE | SHS | 8.30M | SH | $31.13M 5.10% | 8.30M | 0.00 | 0.00 |
KURA ONCOLOGY INCSOLE | COM | 3.36M | SH | $27.29M 4.48% | 3.36M | 0.00 | 0.00 |
ALNYLAM PHARMACEUTICALS INCSOLE | COM | 76K | SH | $25.15M 4.12% | 76K | 0.00 | 0.00 |
MEIRAGTX HLDGS PLCSOLE | COM | 2.63M | SH | $22.78M 3.73% | 2.63M | 0.00 | 0.00 |
ALKERMES PLCSOLE | SHS | 513.63K | SH | $18.16M 2.98% | 513.63K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 770K | SH | $17.99M 2.95% | 770K | 0.00 | 0.00 |
VEEVA SYS INCSOLE | CL A COM | 86.48K | SH | $15.19M 2.49% | 86.48K | 0.00 | 0.00 |
ZYMEWORKS INCSOLE | COM | 539.05K | SH | $13.50M 2.21% | 539.05K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 350K | SH | $12.71M 2.08% | 350K | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 105K | SH | $11.69M 1.92% | 105K | 0.00 | 0.00 |
CONCENTRA GROUP HOLDINGS PARSOLE | COMMON STOCK | 505.82K | SH | $10.85M 1.78% | 505.82K | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | COM | 202.30K | SH | $10.67M 1.75% | 202.30K | 0.00 | 0.00 |
PHREESIA INCSOLE | COM | 1.10M | SH | $9.22M 1.51% | 1.10M | 0.00 | 0.00 |
ONKURE THERAPEUTICS INCSOLE | COM CL A | 2.15M | SH | $8.92M 1.46% | 2.15M | 0.00 | 0.00 |
CORBUS PHARMACEUTICALS HLDGSSOLE | COM NEW | 697.11K | SH | $6.55M 1.07% | 697.11K | 0.00 | 0.00 |
SCHRODINGER INCSOLE | COM | 510.58K | SH | $5.80M 0.95% | 510.58K | 0.00 | 0.00 |
EMERGENT BIOSOLUTIONS INCSOLE | COM | 639.12K | SH | $5.30M 0.87% | 639.12K | 0.00 | 0.00 |
ROIVANT SCIENCES LTDSOLE | SHS | 180K | SH | $4.99M 0.82% | 180K | 0.00 | 0.00 |
Page 1 of 2